Close

MKKGY and MRK Related Headlines

Go Back

Apr 17, 2024 08:00AM MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
Apr 16, 2024 08:00AM MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
Mar 20, 2024 11:03AM MilliporeSigma Invests More than € 300 Million in New Life Science Production Site in Korea
Feb 29, 2024 08:00AM EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
Jan 22, 2024 05:00PM Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Jan 4, 2024 08:00AM Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
Dec 5, 2023 02:00PM MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
Nov 14, 2023 12:30PM EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District
Nov 14, 2023 08:00AM MilliporeSigma Launches ChemisTwin™, First Ever Digital Reference Material Platform for Analytical Testing
Oct 16, 2023 02:00AM EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
Oct 16, 2023 02:00AM EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
Oct 11, 2023 02:15AM Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
Oct 10, 2023 02:15AM EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
Oct 5, 2023 02:30PM EMD Serono Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Caregivers
Oct 5, 2023 08:02AM EMD Serono Launches New Collaboration with United Nations’ Global Initiative on Ageing to Support Caregivers
Sep 26, 2023 04:00AM MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
Jul 25, 2023 07:46AM Data Vault Holdings, Inc. and p-Chip Corporation to Connect Platforms through Enabling IP Licensing Agreement
Jul 12, 2023 11:30AM MilliporeSigma Invests $25 Million to Expand Cell Culture Media Production in Kansas
Jul 11, 2023 09:05AM Athinia™ expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance
Jun 6, 2023 08:00AM MilliporeSigma Announces Proteologix as Winner of its North American Advance Biotech Grant
May 25, 2023 05:05PM EMD Serono Highlights Commitment to Improving Cancer Outcomes at ASCO 2023

MKKGY and MRK Related Press Releases

Go Back

Apr 17, 2024 08:00AM MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour
Apr 16, 2024 08:00AM MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing
Mar 20, 2024 11:03AM MilliporeSigma Invests More than € 300 Million in New Life Science Production Site in Korea
Feb 29, 2024 08:00AM EMD Serono Presents New MAVENCLAD® Data Supporting Cognitive Function Benefits
Jan 22, 2024 05:00PM Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Jan 4, 2024 08:00AM Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
Dec 5, 2023 02:00PM MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
Nov 14, 2023 12:30PM EMD Serono Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District
Nov 14, 2023 08:00AM MilliporeSigma Launches ChemisTwin™, First Ever Digital Reference Material Platform for Analytical Testing
Oct 16, 2023 02:00AM EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
Oct 16, 2023 02:00AM EMD Serono to Present Latest Research from Oncology Portfolio at ESMO 2023
Oct 11, 2023 02:15AM Evobrutinib, CNS-Penetrant BTKi, Has Shown Sustained Clinical Benefit Up to Five Years in People with RMS
Oct 10, 2023 02:15AM EMD Serono Presents New MAVENCLAD® (Cladribine) Tablets Data Highlighting Sustained Reduction in NfLs and Benefit of Early Initiation
Oct 5, 2023 02:30PM EMD Serono Launches New Collaboration with United Nations-Guided Global Initiative on Ageing to Support Caregivers
Oct 5, 2023 08:02AM EMD Serono Launches New Collaboration with United Nations’ Global Initiative on Ageing to Support Caregivers
Sep 26, 2023 04:00AM MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services
Jul 25, 2023 07:46AM Data Vault Holdings, Inc. and p-Chip Corporation to Connect Platforms through Enabling IP Licensing Agreement
Jul 12, 2023 11:30AM MilliporeSigma Invests $25 Million to Expand Cell Culture Media Production in Kansas
Jul 11, 2023 09:05AM Athinia™ expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance
Jun 6, 2023 08:00AM MilliporeSigma Announces Proteologix as Winner of its North American Advance Biotech Grant
May 25, 2023 05:05PM EMD Serono Highlights Commitment to Improving Cancer Outcomes at ASCO 2023

MKKGY and MRK Related SEC Filings

Go Back